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Objectives. This study was designed to evaluate and compare 
the patterns of arrhythmogenic right ventricular cardiomyopathy 
in young people and adults. 
Background. Few data are available on this cardiomyopathy in 
young people because clinical and morphologic findings consid- 
ered pathognomonic are normally based on observations in 
adults. However, a familial occurrence with a probable genetic 
transmission led to the study of children and to early detection of 
this disease, in which sudden death has been reported even in 
young people. 
Methods. Seventeen young patients with arrhythmogenic right 
ventricular cardiomyopathy diagnosed at a mean age -+ SD of 
14.9 -+ 4.9 years were studied. Clinical, electrocardiographic, 
echocardiographic, cineangiographic and biopsy findings were 
compared with those of 19 adult patients whose condition was 
diagnosed at a mean age of 38.1 + 13.4 years. 
Results. Syncope occurred in 23.5% of the young patients but in 
none of the adults (odds ratio of familial sudden death 5.54, p = 
0.1). Ventricular couplets (odds ratio 16.0, p = 0.004) and 
subtricuspid bulging on echocardiography (odds ratio 5.95, p = 
0.036) were prevalent in the young group. Cineangiographic data 
in the two groups were similar, except hat more hypokinetic areas 
were found in adults (odds ratio 4.44, p = 0.05). Morphometric 
analysis of biopsy sections showed a greater amount of fibrous 
tissue in the young patients (p = 0.04) and a prevalence of fatty 
tissue in the adults (odds ratio 12, p = 0.005). During an 
equivalent follow-up time (mean 7 years), two young patients died 
suddenly, and two had ventricular fibrillation in the absence of 
antiarrhythmic therapy. 
Conclusions. The pathognomonic riteria for the diagnosis of 
arrhythmogenic right ventricular cardiomyopathy in adults are 
also valid for young people. Sudden or aborted death occurred 
frequently in young untreated patients. 
(J Am Coil Cardiol 1995;25:655-64) 
Arrhythmogenic right ventricular cardiomyopathy is a primary 
myocardial disease, characterized by adipose or fibroadipose 
substitution of the right ventricle. The clinical diagnosis is 
formulated in patients who have ventricular arrhythmias with a 
left bundle branch configuration (1-5), abnormal T wave 
inversion in precordial leads (6), increased right ventricular 
volume, localized or diffuse trabecular disarrangement and 
dynamic abnormalities of the right ventricular free wall in the 
absence of intracardiac shunts, active myocarditis, pulmonary 
hypertension and valvular or coronary artery disease (7-15). 
The clinical, morphologic and functional findings consid- 
ered pathognomonic of arrhythmogenic right ventricular car- 
diomyopathy are usually based on observations in adults. 
However, the discovery of a familial occurrence with probable 
genetic transmission led to the study of children as well (16) 
and then to early detection of the disease (17-22). 
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To better define this cardiomyopathy, weexamined apanel 
of variables in patients in whom the disease was diagnosed 
before the age of 20 years and compared these findings with 
those of a control group of adult patients. 
Methods  
Young patients were defined as those whose cardiomyopa- 
thy was diagnosed before age 20 years; this group comprised 17 
patients, 12 male and 5 female, with a mean age _+ SD at 
diagnosis of 14.9 - 4.9 years. The following clinical variables 
were considered: gender, familial occurrence of sudden death, 
age at onset of first symptoms, age at diagnosis and clinical 
presentation of first symptoms (palpitation, syncope or lipo- 
thymia [or both], anginalike pain, fatigue). 
The electrocardiographic (ECG) variables of interest were 
axis, duration and abnormalities of the QRS complex and T 
waves in precordial leads. Ventricular arrhythmias were re- 
corded by ECG or Holter monitoring or induced by ECG 
stress testing. Three or more premature ventricular complexes 
were defined as nonsustained ventricular tachycardia. 
Signal-averaged lectrocardiography (23) in the time domain 
was performed with a Marquette MAC 15 system, recording 
standard orthogonal leads X, Y and Z. The signals of the three 
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leads were bandpass-filtered digitally at 25/250 Hz and 
40/250 Hz and combined into a vector magnitude waveform V
(V=square root of the sum of X 2 -l- y2 + z2). From this 
waveform of the filtered QRS complex, the following variables 
were derived: QRS duration, the root mean square voltage of 
the terminal 40 ms (RMS) and the duration of the low 
amplitude signal (LAS) below 40 txV in the terminal portion of 
the filtered QRS complex. A total of 250 to 400 beats were 
averaged to obtain a noise level <0.7 txV. Normal values were 
evaluated in150 subjects (88 male, 62 female; mean age 28.6 _+ 
11.5 years [range 5 to 50] with a QRS complex width -<100 ms 
(mean 85 -+ 8) on the standard 12-lead ECG. The limits of 
normality for the 25-Hz filter and the 40-Hz filter, respectively, 
were QRS -<124 and ---114 ms; LAS -<23 and -<32 ms; RMS 
->53 and ->28 ttV. Late potentials were considered present 
when at least two of three variables were abnormal in one of 
the two filters. According to these criteria of positivity, speci- 
ficity was 84% for the 25-Hz filter and 87% for the 40-Hz filter. 
The specificity was calculated on the basis of data obtained 
from 116 subjects (69 male, 47 female; mean age 29.1 _+ 11.7 
years [range 6 to 58]), with arrhythmogenic right ventricular 
cardiomyopathy who were studied in our department. 
Eleetrophysiologic studies, performed in 14 of the 17 pa- 
tients, included evaluation of the baseline conduction i terval, 
assessment of atrioventricular node conductivity and refracto- 
riness and right ventricular pacing to induce ventricular ar- 
rhythmias. The protocol for pacing consisted of the triple 
extrastimuli technique, in the absence of isoproterenol infu- 
sion, in the three regions of the right ventricle most involved by 
the disease (infundibular, apical and subtricuspid regions). 
Nonsustained ventricular tachycardia was defined as three or 
more consecutive ventricular beats, lasting <30 s, at a rate 
> 120 beats/min. Sustained ventricular tachycardia was defined 
as a tachycardia that lasted >30 s, caused cardiovascular 
collapse with loss of consciousness or required intervention for 
termination. 
The transthoracic e hocardiogram included views of the right 
ventricle with particular attention to the subtricuspid and 
infundibular areas, wall motion abnormalities (hypokinesia 
and akinesia) and trabecular disarrangement. Echocardio- 
graphic images obtained by cross-sectional examinations were 
evaluated for the presence of abnormal wall motion and 
structural abnormalities by two independent observers who 
had no knowledge of patient data and who used frame by 
frame analysis and observation in real time. Wall motion 
abnormalities and structural changes were assigned to a pa- 
tient only if the two observers were in agreement. 
Hemodynamic and cineangiographic data of the right ventri- 
cle included end-diastolic volume, obtained by the area-length 
method; end-systolic volume; ejection fraction; apical, dia- 
phragmatic and anterior free wall kinetic anomalies; the 
presence of anterior or posterior wall bulging, and the arrange- 
ment of hypertrophic trabeculae (longitudinal or transverse). 
We also considered the following variables in the left ventricle: 
cineangiographic end-diastolic volume as assessed by the 
monoplanar method of Green; ejection fraction; left ventricu- 
lar mass and stress, determined according to the method of 
Kennedy et al. (24) and Falsetti et al. (25), respectively; ratio of 
mass to end-diastolic volume; ratio of stress to end-systolic 
volume, and ventricular kinetics. 
The 17 young patients with arrhythmogenic right ventricu- 
lar cardiomyopathy were compared with 19 adults with ar- 
rhythmogenic right ventricular cardiomyopathy who had an 
equal follow-up time after the initial diagnosis and had under- 
gone the same clinical and laboratory investigations. These 19 
adults (11 men and 8 women) had a mean age of 38.1 +_ 13.4 
years (range 22 to 63) at the time of diagnosis. 
To validate the clinical diagnosis, endomyocardial biopsy 
was performed uring hemodynamic study in 29 patients (12 
young, 17 adult). Samples were obtained at the confluence 
between the ventricular septum and the anterior free wall, 
close to the apex. For control samples, we used tissue from 29 
biopsies performed indonor hearts at the time of first biopsy 1 
week after heart ransplantation; i  16 cases, the samples were 
collected from patients -<20 years old (mean age 16.6 _+ 2.8) 
and in 13 cases they were from patients >20 years old (mean 
age 31.1 _+ 7.3). 
Three to five biopsy specimens from each patient were 
examined; all specimens were embedded in the same paraffin 
block and observed on the same slide. The percent area of the 
following variables was determined: myocytes, interstitium 
(excluding fibrous and fatty tissue), fibrous tissue and fatty 
tissue (26). A Kontron IBAS II image analyzer connected by a 
television camera to a microscope was used. The signal coming 
from the camera was viewed in black and white (768 x 512 
pixels), and the image was stored and analyzed (27). 
Statistical analysis. Continuous values were expressed as 
mean value _+ 1 SD. Findings in the young and adult patients 
were compared by Student wo-tailed t test; the effect of 
categoric variables was reported either as a percentage oras an 
odds ratio for cross-sectional prevalence data, with their 90% 
confidence limits. A two-tailed probability value <0.1 was 
considered suggestive and -<0.05 statistically significant. 
Resul ts  
Clinical presentation. Among the young patients, the male/ 
female ratio was 2.4:1 and the mean age at symptom onset was 
12.3 +_ 3 years. In 5 patients, the symptoms consisted of 
consciousness abnormalities ( yncope in 4, lipothymia in 1); 10 
patients experienced palpitation, and 2 reported chest pain, 
which was anginalike in i patient. Two of the four patients with 
syncope were admitted to the hospital; the surface ECG 
showed ventricular tachycardia in one patient and ventricular 
fibrillation in the other; both were treated with electrical 
cardioversion. Four patients had a family history of sudden 
death. 
Among the adults, the male/female ratio was 1.3:1 and the 
mean age at symptom onset was 33.8 +_ 13.2 years. Seven 
patients described episodes of lipothymia, but syncope was 
never reported; 11 patients experienced palpitation, and 1 
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Table 1. Late Potentials 
Pt QRS25 LAS25 RMS25 QRS40 LAS40 RMS40 
No. (ms) (ms) (pN) (ms) (ms) (/zV) Results 
Young Patients 
1 161 57 4 157 67 3 + 
2 . . . . . . . . . . . . . . . . . . . . .  
3 134 25 63 133 38 19 + 
4 118 17 92 105 29 76 - 
5 160 55 6 159 81 4 + 
6 165 56 14 158 57 9 + 
7 122 13 67 112 15 37 - 
8 115 13 86 103 17 82 - 
9 125 15 71 111 13 64 
10 131 14 71 130 45 20 + 
11 142 22 45 130 39 24 + 
12 120 17 170 109 24 82 
13 135 50 15 126 51 l0 + 
14 137 52 13 152 58 8 + 
15 . . . . . . . . . . . . . . . . . . . . .  
16 125 23 76 108 22 95 + 
17 117 14 76 108 30 46 - 
Adult Patients 
18 148 36 29 137 57 21 + 
19 126 74 10 116 43 6 + 
20 . . . . . . . . . . . . . . . . . . . . .  
21 . . . . . . . . . . . . . . . . . . . . .  
22 118 32 68 112 39 20 + 
23 . . . . . . . . . . . . . . . . . . . . .  
24 115 20 57 99 34 45 - 
25 122 23 42 114 35 23 + 
26 . . . . . . . . . . . . . . . . . . . . .  
27 . . . . . . . . . . . . . . . . . . . . .  
28 125 27 62 104 18 52 - 
29 137 17 42 167 89 2 + 
30 123 41 29 116 47 12 + 
31 122 12 53 111 36 26 + 
32 127 15 71 116 33 48 - 
33 . . . . . . . . . . . . . . . . . . . . .  
34 205 70 15 196 112 8 + 
35 146 43 10 143 67 4 + 
36 118 13 107 122 29 30 - 
LAS25 and LAS40 = low amplitude signal duration at 25 and 40 Hz; Pt = patient; QRS25 and QRS40 = total QRS 
duration at 25 and 40 Hz; RMS25 and RMS40 = root mean square voltage of the last 40 ms of the QRS complex at 25 
and 40 Hz; . . .  = not available; - = negative; + = positive. 
patient had chest pain. Only one patient had a family history of 
sudden death. 
The prevalence of syncope in the young group (4 of 17) was 
23.5% (90% confidence limits [CL]) versus 0 (9.1 to 46.7) in 
the adult group (p Fisher = 0.08); the odds ratio of familial 
sudden death in the young was 5.54 (0 to 16.7) (p = 0.1). 
Electrocardiographic findings on ECG or Holter monitor- 
ing. In the young group, the mean QRS axis was +40 _+ 40 °, 
with a mean duration of 0.08 + 0.01 s; in 10 patients, a right 
intraventricular delay was present (rS pattern in lead V1; $1, $2, 
S 3 in the limb leads), and in 2 patients, the QRS complex 
showed a right bundle branch block (rSr' in lead V1). In the 
precordial leads, the T waves were negative over lead V 2 in 
nine patients. The initial arrhythmias recorded on the surface 
ECG or Holter monitor were ventricular extrasystoles in four 
patients, couplets in eight, and triplets, nonsustained ventric- 
ular tachycardia, sustained ventricular tachycardia, ventricular 
fibrillation and atrial fibrillation in one patient each. All 
ventricular arrhythmias had a left bundle branch block config- 
uration. 
Signal-averaged electrocardiography was performed in 15 
young patients (Table 1); the two patients with right bundle 
branch block were excluded. The mean QRS values obtained 
with 25- and 40-Hz bandpass filters were 133 _+ 17 and 125 + 
20 ms, respectively, whereas the respective values for the mean 
duration of the LAS were 28 _+ 18 and 38 _+ 20 ms, and those 
658 DALIENTO ET AL. JACC Vol. 25, No. 3 
ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY March 1, 1995:655-64 
for the mean RMS of the last 40 ms were 61 + 43 and 41 - 
33/xV. In nine patients, findings were positive for the presence 
of late potentials. 
In the adult group, the mean QRS axis was +23 _+ 36 °, with 
a mean duration of 0.09 _ 0.01 s. Six patients had a right 
intraventricular delay with an rS pattern in lead V 1 and St, $2, 1 
S 3 in the limb leads; right bundle branch block was observed in 2 
3 
three. In the precordial leads, negative T waves over lead V 2 
were observed in nine patients. The first documented arrhyth- 4 
mias were ventricular extrasystoles in eight patients, couplets 5 
in one patient, triplets in two patients, and nonsustained and 6 
sustained ventricular tachycardia in four patients each; the 7 
ventricular arrhythmias presented a left bundle branch config- 8 
9 uration. Signal-averaged electrocardiography was performed 
in 13 patients; the 3 patients with right bundle branch block l0 
were excluded. At 25 and 40 Hz, the mean QRS values were 11 
133 + 24 and 127 + 27 ms, respectively, whereas the respective 12 
mean values for LAS were 32 - 20 and 49 _+ 26 ms, and for 13 
mean RMS were 46 + 28 and 23 _+ 17/xV. Nine patients were 14 
considered to have positive findings for the presence of late 15 
16 
potentials. 17 
Statistical analysis showed that the QRS duration was 
slightly but significantly longer (p = 0.03) in the adult than in 
the young patients, probably because the older group had a 18 
larger proportion of patients with right bundle branch block. 19 
The groups did not differ in QRS or T wave configuration i  20 
the precordial eads. Couplets were more prevalent in the 21 
young (odds ratio 16 [90% CL 2.47 to 103] [p = 0.004]). 22 
23 
Arrhythmias on stress testing and electrophysiologic study. 24 
No episode of sustained ventricular tachycardia was induced 25 
during stress testing in either the young or the adult patients 26 
(Table 2). At electrophysiologic study, the inducibility of 27 
sustained ventricular tachycardia mong patients who had 28 
never had this arrhythmia was limited to one patient in the 29 
3O young group. In three patients a polymorphic nonsustained 
31 
ventricular tachycardia (maximum of five beats) was induced 32 
with two ventricular extrastimuli (coupling interval in leads V1 33 
to V 2 and V2 to V 3, respectively, 260 and 220 ms [Patient 16], 34 
250 and 210 ms [Patient 11] and 250 and 200 ms [Patient 36]). 35 
Morphologic and functional data. Echocardiography. In the 36 
young group, trabecular disarrangements were detected in 13 
patients; this abnormality was limited to a single region in 10 
patients and involved several regions in 3. Subtricuspid bulging 
was observed in 7 patients, and 10 showed regional wall motion 
abnormalities (hypokinesia in 7 and akinesia in 3) (Table 3). 
In the adult group, trabecular disarrangements were ob- 
served in 12 patients. Subtricuspid bulging was evident in 2 
patients, whereas dynamic anomalies were seen in 12 (hypoki- 
nesia in 5 and akinesia in 7). 
Statistical analysis howed that the odds ratio of subtricus- 
pid bulging in the young was 5.95 (90% CL 1.36 to 25.9) (p = 
0.036). 
Quantitative cineangiographic analysis. In the young group 
(Table 4), the right ventricular cavity was dilated (mean 139 - 
34 ml/m2), with a mild reduction in ejection fraction (50 _+ 
13%). The end-diastolic volume of the left ventricle was 
Table 2. Clinical and Inducible Arrhythmias 
Pt Clinical Arrhythmias at Arrhythmias at 
No. Arrhythmias Stress Test  Electrophysiologic Study 
Young Patients 
SVT NSVT MSVT 
Couplets PVC None 
SVT None MSVT + Atrial 
Fibrillation 
PVC PVC ...  
VF None None 
Couplets PVC None 
PVC NSVT ...  
NSVT NSVT ...  
SVT None MSVT + Atrial 
Fibrillation 
IARV None IARV 
PVC NSVT PNSVT 
VF NSVT None 
NSVT PVC MSVT 
NSVT PVC MNSVT 
PVC PVC None 
NSVT Couplets PNSVT 
PVC PVC None 
Adult Patients 
NSVT NSVT MNSVT 
SVT NSVT MSVT 
PVC NSVT None 
Couplets PVC None 
SVT None MSVT 
NSVT PVC None 
SVT NSVT MNSVT 
SVT PVC MSVT 
SVT None None 
SVT PVC None 
Couplets PVC None 
SVT PVC MSVT 
Couplets None None 
Couplets None IARV 
NSVT None None 
SVT NSVT MSVT 
NSVT NSVT None 
SVT None MSVT 
NSVT PVC PNSVT 
IARV = accelerated idioventricular rhythm; MNSVT = monomorphic 
nonsustained ventricular tachycardia; MSVT = monomorphic sustained ventric- 
ular tachycardia; NSVT = nonsustained ventricular tachycardia; PNSVT = 
polymorphic nonsustained ventricular tachycardia; Pt = Patient; PVC = prema- 
ture ventricular complexes; SVT - sustained ventricular tachycardia; VF = 
ventricular fibrillation; . . .  = not performed. 
normal (mean 90 _+ 29 ml/m2), with normal values for ejection 
fraction (60 _+ 6%), stress/end-systolic volume ratio (5.4 _+ 2) 
and mass/volume ratio (0.8 _+ 0.1). 
In the adult group, the mean right ventricular end-diastolic 
volume was 139 _+ 48 ml/m 2 and the ejection fraction was 51 _+ 
9%. The left ventricle end-diastolic volume was slightly in- 
creased (93 _+ 36 ml/m2), with normal values for ejection 
fraction (61 _+ 9%), mass/volume ratio (1 _+ 0.2) and stress/ 
end-systolic volume ratio (6.8 _+ 2.7). 
JACC Vol. 25, No. 3 DALIENTO ET AL. 659  
March 1, 1995:655-64 ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 
Table 3. Echocardiographic Findings in the Right Ventricle 
Pt Trabecular Subtricuspid 
No. Disarrangement Bulging Hypokinesia Akinesia 
Young Patients 
1 1 region + 1 region - 
2 2 regions - 1 region 
3 + - - 
2 regions - - 
5 1 region 1 region 
6 - - 1 region 
7 1 region - - - 
8 1 region - - 
9 1 region - - - 
10 2 regions + 1 region - 
11 1 region + 1 region 
12 - - - 
13 1 region + 1 region - 
14 1 region + 1 region - 
15 . . . . . . . . . . . .  
16 1 region 1 region - 
17 1 region ,- - 1 region 
Adult Patients 
18 1 region 1 region 
19 1 region - 1 region 
20 1 region - - 1 region 
21 I region 1 region 
22 1 region - - 
23 - - 
24 1 region - 1 region 
25 1 region + - - 
26 . . . .  
27 - - - 
28 1 region + - 1 region 
29 1 region - - 1 region 
30 1 region 
31 1 region - - 1 region 
32 - 1 region 
33 1 region - - 1 region 
34 - 
35 - - 1 region 
36 - 1 region 
Pt = patient; . . .  = not available; - = not present; + = present. 
Statistical analysis showed overlapping of the functional 
indexes of the two ventricles in the young and adult groups. 
Qualitative cineangiographic findings in the right ventricle. In 
the young group, qualitative cineangiography of the right ven- 
tricle (Table 5) showed both apical and diaphragmatic hypo- 
kinesia in three patients, localized apical hypokinesia in seven 
and localized diaphragmatic hypokinesia in one patient. End- 
diastolic bulging was present in all patients, and was both 
subtricuspid and anterior in eight, subtricuspid in four and 
anterior in three. An abnormal trabecular pattern was ob- 
served in 13 patients. 
In the adult group, both the apical and diaphragmatic walls 
were hypokinetic in 10 patients; localized hypokinesia of the 
apical walls was found in 7. End-diastolic bulging was present 
Table 4. Quantitative Angiographic Variables of Right 
Ventricular Function 
Pt RVEDV RVEF LVEDV LVEF 
No. (ml/m z) (%) (ml/m 2) (%) M/LVEDV S/LVESV 
Young Patients 
1 194 49 101 74 1.07 4.1 
2 155 62 70 58 0.87 7.89 
3 110 44 60 70 0.9 6.5 
4 118 69 76 73 0.95 5.1 
5 100 50 80 55 0.9 6.3 
6 160 50 75 65 0.9 6.3 
7 . . . . . . . . . . . . . . . . . .  
8 . . . . . . . . . . . . . . . . . .  
9 123 56 92 55 1.03 2.87 
10 149 42 119 64 0.9 4.63 
11 223 49 168 49 0.95 1.28 
12 124 49 96 61 0.81 6.16 
13 99 30 70 61 0.9 5.5 
14 114 23 68 53 0.95 5.4 
15 145 51 69 62 0.9 6.3 
16 145 51 111 62 0.87 4.24 
17 137 72 106 65 0.7 7.41 
Adult Patients 
18 165 44 100 62 0.7 7 
19 131 40 182 50 0.8 3.4 
20 65 51 75 60 0.95 6 
21 130 62 92 58 1.16 6.4 
22 144 50 67 66 1 7 
23 97 69 44 65 1.4 10.7 
24 90 61 44 62 1.3 10.5 
25 119 44 70 63 1 7 
26 117 58 93 61 1 4 
27 75 56 44 65 1.4 10.7 
28 161 40 122 50 1.1 10.7 
29 140 38 101 50 1.2 4.5 
30 171 56 90 80 1.2 10.5 
31 130 51 67 50 0.7 9.8 
32 148 53 102 56 0.8 6 
33 146 49 119 75 0.7 6.6 
34 212 60 145 64 0.9 4.8 
35 120 55 70 52 1 6.5 
36 279 37 118 74 0.67 3.56 
LVEDV = left ventricular end-diastolic volume; LVEF = left ventricular 
ejection fraction; M/LVEDV - mass/left ventricular end-diastolic volume ratio; 
Pt = patient; RVEDV = right ventricular end-diastolic volume; RVEF = right 
ventricular ejection fraction; S/LVESV = stress/left ventricular end-systolic 
volume ratio; . . .  = not available. 
in all patients and was subtricuspid and anterior in 12, subtri- 
cuspid in 6 and anterior in 1 patient. An abnormal trabecular 
pattern was observed in 17 patients. 
Statistical analysis showed that the odds ratio for apical and 
diaphragmatic hypokinesia in the adults (10 of 19) versus the 
young (3 of 15) was 4.44 (90% CL 1.21 to 16.4) (p = 0.05). 
Morphometric analysis of endomyocardial biopsy speci- 
mens. In the 12 biopsy specimens obtained in the young group 
(Table 6), 50.2 _+ 12.9% of the area was occupied by myocytes, 
11.9 = 3.7% by interstitium, 5.3 +_ 5.8% by fatty tissue and 
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Table 5. Qualitative Angiographic Findings in the Right Ventricle 
Pt Ap ica l  D iaphragmat ic  Hypert rophic  Subtricuspid Anterior 
No. Walls Walls Trabeculae Bulging Bulging 
Young Patients 
1 Hypokinetic Hypokinetic Transverse + + 
2 - Hypokinetic Longitudinal + + 
3 Hypokinetic Longitudinal + - 
4 - + + 
5 Hypokinetic Transverse + - 
6 Hypokinetic - Transverse + + 
7 . . . . . . . . . . . . . . .  
8 . . . . . . . . . . . . . . .  
9 Hypokinetic Transverse + - 
l0 Hypokinetic Transverse + + 
11 - Transverse + 
12 - + + 
13 Hypokinetic Transverse + + 
14 Hypokinetic Hypokinetic Transverse + - 
15 Hypokinetic Hypokinetic Transverse + + 
16 Hypokinetic Transverse * 
17 - Transverse + 
Adult Patients 
18 Hypokinetic Hypokinetic Transverse + + 
19 Hypokinetic Hypok inet i c  Longitudinal + + 
20 - Transverse + 
21 Hypokinetic - Transverse + + 
22 - - Longitudinal + + 
23 Hypokinetic - Transverse + - 
24 Hypokinetic Hypokinetic Transverse + - 
25 Hypokinetic + + 
26 Hypokinetic Hypok inet i c  Longitudinal + - 
27 Hypokinetic - Longitudinal + + 
28 Hypokinetic Hypokinetic Transverse + + 
29 Hypokinetic Hypokinetic Longitudinal + - 
30 Hypokinetic Hypok inet i c  Longitudinal + + 
31 Hypokinetic Hypokinetic - + 
32 Hypokinetic Longitudinal - + 
33 Hypokinetic - Transverse + + 
34 Hypokinetic Hypokinetic Transverse + + 
35 Hypokinetic - Transverse + + 
36 Hypokinetic Hypokinetic Transverse + + 
Pt = patient; ... = not available; - = not present; + = present. 
35.6 - 14.3% by fibrous tissue. Adipocytes were not present in 
10 patients. In the young control donor group, the area 
occupied by myocytes was 79.5 _+ 6.7% (p < 0.001), by 
interstitium 11.2 _ 6.8% (p = NS) and by fibrous tissue 6.3 _+ 
4.8% (p < 0.001). No subject in the control group showed fatty 
tissue. 
In the 17 endomyocardial biopsy specimens obtained in the 
adults, 47.4 _+ 15.5% of the area contained myocytes, 14.5 _+ 
4.8% interstitium, 17.6 _+ 17.7% fatty tissue and 25.2 _+ 11.4% 
fibrous tissue. Adipocytes were not present in five patients. In 
the adult control donor group, the area occupied by myocytes 
was 77,7 _+ 6.4% (p < 0.001), by interstitium 13.0 _+ 3.2% (p = 
NS) and by fibrous tissue 8.1 - 3.4% (p < 0.001). Only one 
subject in the adult control donor group showed the presence 
of fatty tissue (2.3% of the area). 
Statistical analysis disclosed a different qualitative distribu- 
tion of fatty tissue in the two patient groups. The odds for fatty 
tissue prevalence in the adults were 12 (90% CL 2.55 to 56.3) 
(p = 0.005). The percent of area occupied by fibrous tissue was 
more significant in the young than in the adult patients (p = 
0.04). Two young patients versus three adult patients showed 
inflammatory lymphocyte infiltration (p = NS). 
Follow-up. The duration of follow-up in the young and 
adult groups was equivalent (7.0 _+ 3.7 vs. 7.2 + 3.3 years). 
Young patients. Two patients in the young group died 
suddenly. The first sudden death occurred during effort in a 
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Table 6. Morphometric Analysis of Biopsy" Specimens 
Myocytes Interstitium Fatty Tissue Fibrous Tissue Fibrous t Fatty Tissue Inflammatory 
Pt No. (area %) (area %) (area %) (area %) (area %) Infiltrates 
Young Patients 
l 30.3 11.6 - 58 58 - 
2 47.6 18.4 9.5 24.9 34.4 + 
3 50.8 9.7 1.2 38.1 39.3 
4 66.0 16.3 - 17.6 17.6 - 
5 . . . . . . . . . . . . . . . . . .  
6 46.5 6.6 - 31.6 31.6 + 
7 . . . . . . . . . . . . . . . . . .  
8 . . . . . . . . . . . . . . . . . .  
9 . . . . . . . . . . . . . . . . . .  
10 67.7 10.9 - 21.3 21.3 - 
11 58.0 16.2 - 26.0 26.0 - 
12 59.9 14.3 25.7 25.7 - 
13 39 13 - 48 48 
14 28 10 - 62 62 - 
15 . . . . . . . . . . . . . . . . . .  
16 49 9 - 41.8 41.8 - 
17 59.8 7.1 - 33 33 - 
Adult Patients 
18 21.2 21.2 5.8 50.7 56.5 - 
19 52.3 17.1 - 30.6 30.6 - 
20 59.3 18.9 0.5 21.0 21.5 
21 . . . . . . . . . . . . . . .  - 
22 66.5 14.9 1.4 17.0 18.4 
23 59.0 5.0 19.4 16.6 36.0 - 
24 34.3 19.7 31.5 14.6 46.1 + 
25 72.3 11.7 - 15.1 15.1 - 
26 13.2 11.8 59.3 15.6 74.9 - 
27 32.6 10.3 34.8 22.2 57 - 
28 40.1 8.9 10.0 40.8 50.8 - 
29 46.5 19.2 0.8 32.6 33.4 - 
30 44.2 14.8 26.4 15.3 41.7 - 
31 48.6 20.3 6.0 26.1 32.1 - 
32 53.2 16.0 15.8 9.3 25.1 
33 . . . . . . . . . . . . . . . . . .  
34 60.9 11.8 - 27.1 27.1 + 
35 47.2 7.7 - 44.9 44.9 + 
36 54.9 17.2 - 27.2 27.2 - 
Pt = patient; . . .  = not available; - = not present. 
20-year old woman (Patient 15) who had a history of several 
episodes of syncope and had experienced palpitation since age 
16 years; ventricular extrasystoles with a left bundle branch 
configuration were frequent. Angiography had disclosed an 
enlarged, poorly functioning right ventricle. She was being 
treated with diuretic drugs and digitalis when she died. The 
second sudden death occurred at rest in a 19-year old young 
man (Patient 14), who had been admitted to the hospital at age 
17 years for evaluation of ventricular arrhythmias and cardio- 
megaly. We observed premature ventricular couplets as well as 
nonsustained ventricular tachycardia during Holter monitor- 
ing. The patient had spontaneously suspended amiodarone 
therapy 1 month before he died. 
Two other young patients had been resuscitated from 
ventricular fibrillation. One, a 16-year old girl (Patient 12), had 
experienced a syncopal episode 1 year earlier. After resuscita- 
tion, she was treated with beta-adrenergic blocking agents and 
has had no relapse for 13 years. During a recent Holter 
monitoring, only isolated ventricular extrasystoles were 
present. The other patient (Patient 5) was an 18-year old youth 
who had been admitted to the hospital 6 years earlier for 
severe chest pain and ST segment elevation in right precordial 
leads. Angiographic study had disclosed normal coronary 
arteries in the presence of structural and functional localized 
abnormalities of the right ventricle, but these last were under- 
estimated. After resuscitation, he was treated with disopyra- 
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mide and beta-blockers, and did not experience ventricular 
fibrillation or sustained tachycardia during the next 7 years. 
Three young patients had a history of ventricular tachycar- 
dia. Patient 1 first experienced ventricular couplets at age 14 
years, and 3 years later began to suffer from episodes of 
sustained ventricular tachycardia, with occasional need for 
cardioversion. In response to amiodarone-beta-blocker th r- 
apy, the episodes of ventricular tachycardia became sporadic. 
In Patient 9, syncope from sustained ventricular tachycardia 
was the initiating symptom at age 16 years. During the next 4 
years, he was treated with disopyramide for sporadic episodes 
of atrial flutter, and then with disopyramide plus beta-blockers 
after a new episode of sustained ventricular tachycardia. 
Patient 3 experienced two syncopal episodes during exercise at 
age 12 years; these were followed by a documented pisode of 
sustained ventricular tachycardia, which spontaneously con- 
verted to sinus rhythm. He is currently being treated with 
sotalol. 
Three young patients had nonsustained ventricular tachy- 
cardia at rest; one (Patient 13) was treated with amiodarone, 
one (Patient 16) with beta-blockers and one (Patient 8) with 
beta-blockers together with disopyramide. Exercise-related 
unsustained ventricular tachycardias were recorded in two 
other patients during follow-up; the arrhythmias were success- 
fully controlled by beta-blockers in Patient 7 and by propa- 
fenone in Patient 11. Patients 6and 10 had ventricular couplets 
as the presenting symptoms. One of these (Patient 10) was 
treated with flecainide after symptomatic idioventricular ccel- 
erated rhythm attacks. Among the last three young patients 
who showed ventricular extrasystoles atfirst observation (Pa- 
tients 2, 4 and 17), Patient 2 required beta-blocker t eatment 
when his arrhythmia progressed to ventricular polymorphic 
couplets after 2 years. 
Adult patients. Follow-up in the adult patients disclosed no 
cases of sudden death or resuscitation from cardiac arrest. One 
or more episodes of sustained ventricular tachycardia were 
recorded in nine patients, five of whom were <30 years of age; 
all nine patients were treated. Single-drug therapy was pre- 
scribed in six patients: beta-blocker therapy in Patients 24 and 
26, sotalol in Patient 35, amiodarone in Patients 19 and 25 and 
mexiletine in Patient 27. Combination therapy was used in 
three patients: amiodarone + a beta-blocker Patients 29 and 
33 and a beta-blocker + disopyramide in Patient 22. 
All six patients who had nonsustained ventricular tachycar- 
dia were treated: Patients 23 and 34 with propafenone, Patient 
18 with flecainide, Patient 36 with amiodarone and Patients 20 
and 32 with beta-blockers. This therapy prevented attacks of 
sustained ventricular tachycardia. 
Four patients (Patients 21, 28, 30 and 31) never had an 
arrhythmia more severe than ventricular couplets, and all were 
given beta-blockers for treatment of diffuse morphologic ab- 
normalities in the right ventricle. 
Statistical analysis howed that the risk of sudden death or 
ventricular fibrillation in our study appeared to be limited to 
the young roup (23.5% [90% CL 9.1% to 46.4%] vs. 0% [90% 
CL 0% to 16.7%] in the adults [p Fisher = 0.08]). 
Discussion 
Arrhythmogenic r ght ventricular cardiomiopathy is usually 
diagnosed between the ages of 20 and 50 years. Only in 10% of 
patients is the disease recognized before the age of 20, 
probably because it is concealed uring this span of life. 
However, the finding that sudden death occurs even in young 
people suggests hat the juvenile form of arrhythmogenic right 
ventricular cardiomyopathy is not benign. Familial occurrence 
has been described, thus indicating that some genetic factor 
may be involved. Very recently, our group (26) was able to 
localize the genetic disorder on chromosome 14 by linkage 
analysis carried out in a large affected family. Whether a 
difference does exist in the clinical presentation and natural 
history of arrhythmogenic right ventricular cardiomyopathy in 
the young versus the adult is a controversial issue. 
Diagnostic riteria. Our results demonstrate that the diag- 
nostic criteria for this disease in the young are the same as in 
the adult: electrical instability, negative T waves in precordial 
leads on the surface ECG, localized or diffuse morphologic 
abnormalities of the right ventricle and areas of fibrous or 
fibrous-fatty substitution of myocardial tissue on endomyocar- 
dial biopsy (27,28). Whereas imilar morphologic substrates 
explain the ECG, echocardiographic and angiocardiographic 
findings in young and adult patients, ome features peculiar to 
the young subjects eem to distinguish the clinical aspects and 
natural history of the disease in the two groups. 
Quantitative angiocardiography of the right ventricle 
showed similar values for end-diastolic volume and ejection 
fraction in the young and old patients, although an increase in 
the dyskinetic areas was observed in the adult. On two- 
dimensional echocardiography, a distinctive feature in young 
patients appears to be a diastolic subtricuspid bulging. Our 
normal values for signal averaging electrocardiography are 
different from normal values reported in other series (29): We 
considered normal a value of QRS duration -<100 ms on the 
standard 12-lead ECG. 
Features of arrhythmia. Different ypes of ventricular ar- 
rhythmias were recorded in both young and adult patients with 
arrhythmogenic right ventricular cardiomyopathy, but sus- 
tained ventricular tachycardia prevailed in the adult. In our 
experience, however, the true distinctive features appeared to 
be sudden death and ventricular fibrillation, which occurred 
only in young subjects. These arrhythmic events were not 
preceded by attacks of sustained ventricular tachycardia, nd 
they occurred in young people who were not receiving antiar- 
rhythmic therapy. Although one may speculate whether the 
difference in prognostic severity of electrical instability in 
young versus adult patients is related to a larger amount of 
fibrous tissue in the young, another explanation may be 
advanced. The young patients who died suddenly or were 
resuscitated from ventricular fibrillation were not receiving 
antiarrhythmic treatment, either because they had unwisely 
suspended their therapy or because the arrhythmic risk had 
been underestimated. A ult subjects come to our observation 
with overt findings of arrhythmia and thus are given prompt 
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treatment. We propose that in some young people a sudden 
change from a subclinical to a clinical phase may take place, 
with life-threatening arrhythmias as the first symptom. The 
experience of sudden death as the first clinical manifestation f 
arrhythmogenic right ventricular cardiomyopathy in young 
people and in athletes i in accord with this hypothesis. In the 
adult he disease most probably reaches a stable phase in which 
abrupt changes in electrical instability are less likely. 
Programmed ventricular stimulation did not assume differ- 
ent clinical significance in the young and in the adult patients. 
This technique was useful in patients with clinical ventricular 
tachycardia but did not exclude ventricular fibrillation in the 
young. 
Limitations of the study. There were no instances of 
sudden death or ventricular fibrillation among our adult pa- 
tients; nonetheless, udden death in the adult has been docu- 
mented by other workers (4,31). Its absence in our series might 
be ascribed to a sampling error. Indeed, we selected our adult 
subjects from our cumulative collection of adult cases in 
reference to the young group: that is, an equal follow-up time 
from the onset of symptoms and similar clinical and laboratory 
investigations. Moreover, unlike the young patients, all our 
adult patients were receiving drug therapy. 
Prognosis and prevention of sudden death. That prognosis 
differs according to age is supported by the high frequency of 
sudden death due to arrhythmogenic right ventricular cardio- 
myopathy insubjects <20 years of age (11 of 18) in the Sudden 
Death Registry of the Veneto region (32). Five of those 
autopsy patients were athletes who had been considered to 
have entirely normal findings on periodic clinical examinations 
but showed localized or even widespread right ventricular f ee 
wall fibrous-fatty replacement and aneurysms at postmortem 
study. 
Although we were unable to find specific predictive markers 
of sudden death, our present policy is the following: 1) limit 
physical activity in patients with arrhythmogenic right ventric- 
ular cardiomyopathy; 2) seek identification of affected patients 
with a familial history of this disease; 3) detect deterioration f 
electrical instability in patient follow-up through the use of 
invasive and noninvasive t chniques; 4) provide medical treat- 
ment for patients with sustained or inducible ventricular 
tachycardia, s well as for patients with no arrhythmias in the 
setting of diffuse morphologic right ventricular involvement, 
because drug therapy for arrhythmogenic r ght ventricular 
cardiomyopathy appears to be effective. However, we are 
aware that risk stratification and the management of both 
young and adult patients with arrbythmogenic right ventricular 
cardiomyopathy require further study. 
Nosology. We have used the term cardiomyopathy to de- 
scribe this arrhythmogenic cardiac disorder simply because it is 
a heart muscle disease of unknown etiology and the term thus 
fits the World Health Organization definition (33). One may 
speculate whether the disease should be considered part of the 
condition described by Marcus et al. (1) as "right ventricular 
dysplasia." In our experience, mostly deriving from the Veneto 
region in Italy, the number of sudden deaths in the family 
members of these patients eems to be greater than that of 
patients with the classical form of right ventricular dysplasia. 
Although we are inclined to consider the two clinical entities 
within the spectrum of the same disease, we acknowledge that 
the matter emains controversial nd unresolved. 
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